What is the appropriate dosing regimen of pregabalin for an adult with panic attacks?

Pregabalin Dosing for Panic Attacks

Pregabalin is not FDA-approved for panic disorder, and the available evidence for its use in panic attacks is limited and extrapolated primarily from generalized anxiety disorder (GAD) studies. However, when used off-label for panic disorder, dosing typically follows the GAD regimen.

Recommended Dosing Regimen

Starting Dose

• Begin with 50 mg three times daily (150 mg/day total) or 75 mg twice daily 1
• This lower starting dose helps minimize initial adverse effects, particularly dizziness and somnolence 1

Titration Schedule

• Increase to 300 mg/day after 3-7 days (given as 100 mg three times daily or 150 mg twice daily) 1
• If inadequate response after tolerating 300 mg/day for 2-4 weeks, may increase by 150 mg/day increments every 3-7 days 1

Target and Maximum Doses

• Effective dose range: 300-450 mg/day 2, 3, 4
• Maximum dose: 600 mg/day (200 mg three times daily or 300 mg twice daily) 1, 5, 6
• Doses above 300 mg/day are associated with higher adverse event rates without consistently greater efficacy 1

Important Clinical Considerations

Onset of Action

• Anxiolytic effects may appear as early as Week 1, which is faster than SSRIs but similar to benzodiazepines 1, 3, 4
• An adequate trial requires 4 weeks at the target dose 1

Renal Dosing Adjustments

• Dose reduction is mandatory in patients with renal insufficiency (creatinine clearance <60 mL/min) 1, 5, 1, 5, 6
• Dosage adjustments should be made based on creatinine clearance 1

Discontinuation

• Taper gradually over a minimum of 1 week when discontinuing to minimize withdrawal symptoms 6, 3

Administration

• Can be taken with or without food 6, 7
• Twice-daily or three-times-daily dosing regimens are both acceptable 1

Evidence Limitations and Caveats

Critical limitation: The evidence provided focuses predominantly on neuropathic pain 5 and GAD 8, 9, 2, 3, 4, 10, 11, 12, not specifically panic disorder. Only one long-term study included panic disorder patients alongside GAD and social anxiety disorder 8.

In the long-term anxiety study that included panic disorder patients, pregabalin 150-600 mg/day was generally well tolerated over 1 year, with dizziness (12.5%) being the most common adverse event 8. However, this study was open-label and not placebo-controlled, limiting the strength of conclusions 8.

Common Adverse Effects

• Dizziness and somnolence are dose-dependent and most common 1, 8, 3
• Weight gain occurs in approximately 20-24% of patients with long-term use 8
• Starting with lower doses and titrating cautiously reduces these effects 1

Drug Interactions

• Pregabalin has minimal drug-drug interactions as it undergoes negligible hepatic metabolism and does not affect cytochrome P450 enzymes 7
• No protein binding occurs 7